HappeningToo topic
Osimertinib reports
Browse community reports connected to Osimertinib. These reports can show that other people are describing similar experiences, but they do not prove that Osimertinib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
26 problems
Alopecia while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and alopecia appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and back pain appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and constipation appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and cough appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and decreased appetite appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and dehydration appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and diarrhea appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and dizziness appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and dry skin appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and fatigue appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and headache appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and hypotension appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and insomnia appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and itching appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and malaise appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and muscle spasms appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and myalgia appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and nausea appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and pain appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and peripheral swelling appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and rash appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and shortness of breath appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and skin redness appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and vomiting appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and weakness appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Osimertinib
FDA FAERS contains adverse-event reports in which Osimertinib and weight decreased appear together. This does not establish that Osimertinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →